Erez Hasnis is Senior Physician, Department of Internal Medicine D and Gastointestinal Malignancy Prevention Unit, Institute of Gastroenterology at Rambam Health Care Campus.
Dr. Hasnis graduated from the Rappaport Faculty of Medicine at the Technion, Haifa, where he completed both his MD and PhD degrees. His Phd research focused on activation of the nuclear factor-B in human lymphocytes by reactive nitrogen species, under the supervision of Prof. Abraham Reznick. After army service as a physician, he completed his internal medicine residency and gastroenterology fellowship at Rambam in 2017. Upon completion of his medical training he joined a research fellowship at the Sanford-Burnham-Prebys Medical Discovery Institute in San Diego, CA, under the supervision of Prof. Ze’ev Ronai, where he focused on the role of the E3-ubiquitin ligase RNF125 in growth and differentiation of pancreatic cancer.
Since his return to Rambam, Dr. Hasnis focuses his clinical work in the field of screening for and early detection of pancreatic cancer in high-risk families and individuals with specific germline mutation or a suggestive family history. In addition, Dr. Hasnis provides general GI and internal medicine care in the gastroenterology institute and the internal medicine ward.
In the scientific aspect of his work, Dr. Hasnis is a member of the Clinical Research Institute at Rambam. His research group focuses on identifying novel drivers of the aggressive and therapy resistant phenotype in pancreatic cancer, that can be targeted and manipulated as a therapeutic mean. He is also interested in genetic evolution of colorectal adenomas, and predictive markers for the development of GI malignancies in the general population.
He is the recipient of numerous grants to study different targets in pancreatic cancer, including the ISRF Gesher award, the Israel Cancer Association grant, the Israel Science Foundation grant for physician researchers, and the Dhalia Greidinger grant. He is the author of several scientific publications in the field of pancreatic and colorectal cancer, and performs peer review for gastroenterology and oncology journals.